IN2015DN00085A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00085A
IN2015DN00085A IN85DEN2015A IN2015DN00085A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A IN 85DEN2015 A IN85DEN2015 A IN 85DEN2015A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A
Authority
IN
India
Prior art keywords
compounds
preparation
general formula
methods
well
Prior art date
Application number
Other languages
English (en)
Inventor
Volker Schulze
Franz Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IN2015DN00085A publication Critical patent/IN2015DN00085A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN85DEN2015 2012-07-10 2013-07-03 IN2015DN00085A (it)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
IN2015DN00085A true IN2015DN00085A (it) 2015-05-29

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
IN85DEN2015 IN2015DN00085A (it) 2012-07-10 2013-07-03

Country Status (24)

Country Link
US (1) US9388177B2 (it)
EP (1) EP2872506A1 (it)
JP (1) JP6238979B2 (it)
KR (1) KR20150040845A (it)
CN (1) CN104603136B (it)
AP (1) AP3778A (it)
AU (1) AU2013289381A1 (it)
BR (1) BR112015000308A2 (it)
CA (1) CA2878481A1 (it)
CL (1) CL2015000038A1 (it)
CO (1) CO7160002A2 (it)
CR (1) CR20150006A (it)
DO (1) DOP2015000007A (it)
EA (1) EA027544B1 (it)
HK (1) HK1206731A1 (it)
IL (1) IL236265A (it)
IN (1) IN2015DN00085A (it)
MX (1) MX2015000348A (it)
NZ (1) NZ703020A (it)
PE (1) PE20150354A1 (it)
PH (1) PH12015500061A1 (it)
SG (1) SG11201408419QA (it)
TN (1) TN2015000008A1 (it)
WO (1) WO2014009219A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105431435A (zh) * 2013-06-07 2016-03-23 拜耳制药股份公司 具有作为mps-1抑制剂的活性的取代的三唑并吡啶类
KR20160018534A (ko) 2013-06-11 2016-02-17 바이엘 파마 악티엔게젤샤프트 Mps-1 키나제 억제제 및 유사분열 억제제를 포함하는 암의 치료를 위한 조합물
HUE033131T2 (en) * 2013-06-11 2017-11-28 Bayer Pharma AG Derivatives of substituted triazolopyridines
FI3283642T3 (fi) 2015-04-17 2024-01-11 Crossfire Oncology Holding B V Prognostisia biomarkkereita ttk-inhibiittorikemoterapiaan
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009812A1 (en) * 2001-10-05 2005-01-13 Takuya Seko Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
EP1753428A4 (en) * 2004-05-14 2010-09-15 Abbott Lab INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
BRPI0516819A (pt) * 2004-10-07 2008-09-23 Warner Lambert Co derivados de triazolopiridina e agentes antibacterianos
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
EP2029605A1 (en) * 2006-06-06 2009-03-04 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
WO2008025821A1 (en) 2006-08-30 2008-03-06 Cellzome Limited Triazole derivatives as kinase inhibitors
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
US8053574B2 (en) 2007-07-18 2011-11-08 Novartis Ag Organic compounds
EP2212326A1 (en) 2007-08-23 2010-08-04 AstraZeneca AB 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
WO2009027283A1 (en) 2007-08-31 2009-03-05 Merck Serono S.A. Triazolopyridine compounds and their use as ask inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2009137322A2 (en) * 2008-05-05 2009-11-12 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
US20110212053A1 (en) * 2008-06-19 2011-09-01 Dapeng Qian Phosphatidylinositol 3 kinase inhibitors
EP2396324A1 (en) 2009-02-13 2011-12-21 Fovea Pharmaceuticals Ý1, 2, 4¨triazolo ý1, 5 -a¨pyridines as kinase inhibitors
WO2010124826A1 (en) 2009-04-29 2010-11-04 Bayer Schering Pharma Aktiengesellschaft Substituted imidazoquinoxalines
BRPI1009637A2 (pt) * 2009-06-05 2019-04-30 Cephalon, Inc composto, composição e uso de um composto
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
JP5728683B2 (ja) 2009-09-04 2015-06-03 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH チロシンスレオニンキナーゼ阻害剤としての置換アミノキノキサリン
EP2343295A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343294A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
KR20140025470A (ko) 2011-04-21 2014-03-04 바이엘 인텔렉쳐 프로퍼티 게엠베하 트리아졸로피리딘
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
TN2015000008A1 (en) 2016-06-29
SG11201408419QA (en) 2015-01-29
CN104603136A (zh) 2015-05-06
KR20150040845A (ko) 2015-04-15
US9388177B2 (en) 2016-07-12
AU2013289381A1 (en) 2015-01-22
IL236265A0 (en) 2015-02-26
NZ703020A (en) 2017-08-25
EP2872506A1 (en) 2015-05-20
US20150148542A1 (en) 2015-05-28
JP6238979B2 (ja) 2017-11-29
BR112015000308A2 (pt) 2017-06-27
CR20150006A (es) 2015-02-16
CN104603136B (zh) 2017-06-27
EA027544B1 (ru) 2017-08-31
EA201590116A1 (ru) 2015-07-30
CL2015000038A1 (es) 2015-03-13
DOP2015000007A (es) 2015-02-15
AP3778A (en) 2016-08-31
MX2015000348A (es) 2015-04-14
PE20150354A1 (es) 2015-03-21
CA2878481A1 (en) 2014-01-16
IL236265A (en) 2017-07-31
JP2015523372A (ja) 2015-08-13
AP2014008177A0 (en) 2014-12-31
PH12015500061A1 (en) 2015-03-02
WO2014009219A1 (en) 2014-01-16
CO7160002A2 (es) 2015-01-15
HK1206731A1 (en) 2016-01-15

Similar Documents

Publication Publication Date Title
NZ743274A (en) Substituted tricyclic compounds as fgfr inhibitors
PH12015502839A1 (en) Antiviral compounds
ZA201500316B (en) Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
IL235944A0 (en) β-lactamase inhibitor compounds, preparations containing them, methods for their preparation and their uses
AU2012213775A8 (en) 7-azaindole derivatives
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
MX352881B (es) Metodos y compuestos utiles en la sintesis de antagonistas del receptor de orexina 2.
IN2014MN02598A (it)
EA201590887A1 (ru) Композиция
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
UA114655C2 (uk) Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2
IN2014DN06104A (it)
JO3154B1 (ar) عوامل مضادة لـ trpv4
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
GEP201706626B (en) Synthesis of (s)-nifuratel
PH12015500061A1 (en) Method for preparing substituted triazolopyridines
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
GB201107985D0 (en) Process
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
IN2014DN10135A (it)
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
PH12015502703A1 (en) Pharmaceutical compositions